Inflammatory Bowel Disease (Australia)

Inflammatory bowel disease (IBD) is a medical term that describes a group of conditions in which the gastrointestinal tract (gut) becomes inflamed (red and swollen). Two major types of IBD are Crohn’s disease and ulcerative colitis which are Iife-long gastrointestinal disorders that can present themselves in children, adolescents and adulthood. The relapsing and chronic nature of the disorder has broader impacts on a person’s emotional, physical and social wellbeing.

IBD is an emerging global disease, with Australia having one of the highest prevalences in the world. More than 85,000 Australians live with these conditions, with numbers expected to increase to more than 100,000 by 2022. The conditions are becoming more prevalent, more severe and more complex and are being diagnosed in more and more very young patients.

Crohn’s & Colitis Australia is working in collaboration with the James Lind Alliance to identify the Top 10 research priorities of people with IBD, carers and healthcare professionals. The IBD Research Priorities Project aims to identify unanswered questions that exist related to the prevention, treatment, symptoms, diagnosis and living with IBD. The final list of Top 10 unanswered research questions will be published with the aim to encourage researchers and research funders to focus on the most urgent and relevant needs of people living with IBD.

Key documents

Inflammatory Bowel Disease (IBD) Research Priorities Project (RPP) protocol